Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer By Ogkologos - January 20, 2026 287 0 Facebook Twitter Google+ Pinterest WhatsApp Final findings from the SCOT study Source RELATED ARTICLESMORE FROM AUTHOR Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers MOST POPULAR Woman Suffers Severe Eye Pain And Swelling, Finds Out She Has... April 17, 2019 New Drugs Raise Old Questions about Treating Cancer during Pregnancy May 25, 2022 Understanding FDA Emergency Use Authorization January 21, 2021 How clues from crystals might help us prevent the overtreatment of... June 20, 2023 Load more HOT NEWS Factors Associated with COVID-19 Severity Among Patients with Cancer Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities Glucose Control Key in Reducing Cancer Risk for People with Type... Remembering With Gratitude
